NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE7009 Query DataSets for GSE7009
Status Public on Mar 01, 2007
Title UPF1-depleted HeLa cells - effect on physiological targets
Organism Homo sapiens
Experiment type Expression profiling by array
Summary Nonsense-mediated mRNA decay (NMD) is a molecular pathway of mRNA surveillance that ensures rapid degradation of mRNAs containing premature translation termination codons (PTCs) in eukaryotes. Originally, NMD was thought of as a quality control pathway that targets non-functional mRNAs arising from mutations and splicing errors. More recently, NMD has been shown to also regulate normal gene expression and NMD thus emerged as one of the key post-transcriptional mechanisms of gene regulation. We have now systematically analyzed the molecular mechanism of variable NMD efficiency and used different HeLa cell strains as a model system. The results of this analysis show that NMD efficiency can be remarkably variable and represents a stable characteristic of these strains. Low NMD efficiency is shown to be functionally related to the reduced abundance of the exon junction component RNPS1 in one of the HeLa strain analyzed. Furthermore, restoration of functional RNPS1 expression, but not of NMD-inactive mutant proteins, also restores efficient NMD in the RNPS1 deficient cell line. We conclude that cellular concentrations of RNPS1 modify NMD efficiency and propose that the cell type specific co-factor availability represents a novel principle that controls NMD.
Keywords: NMD UPF1 knock down
 
Overall design HeLa cells were treated with UPF1 siRNA or Luciferase siRNA as a negative control. After 72 hs, cytoplasmic RNA was isolated and the integrity of the RNA was assessed using a Agilent 2100 Bioanalyzer (Agilent, Palo Alto, CA). We performed preparation, processing, and hybridisation of labelled and fragmented cRNA targets to Affymetrix HG_U133A GeneChipsTM according to the manufacturer’s protocols (Affymetrix Inc., Santa Clara, CA). Oligonucleotide arrays were scanned using a confocal laser scanner (GeneArrayTM, Hewlett Packard, Palo Alto, CA). We used the Affymetrix GeneChip Suite 5.0 software (MAS 5.0) to calculate raw expression values for each of the 22,283 probe sets on the U133A oligonucleotide array. Signal intensities were calculated as average intensity difference (AID) between perfect and mismatch probes. Approximately 8,800 probe sets continuously resulting in absent calls were excluded from the analyses. Next, we used GeneSpring 4.2.1 (Silicon Genetics, Redwood City, CA) for scaling, normalisation and background correction of all genes and arrays. We performed Student´s t-test on normalised relative expression ratios to identify significant differentially expressed genes with a minimum factor of difference of >2-fold, within the 95% confidence interval (p<0.05).
 
Contributor(s) Viegas MH, Gehring NH, Breit S, Hentze MW, Kulozik AE
Citation(s) 17586820
Submission date Feb 12, 2007
Last update date Aug 10, 2018
Contact name Marcelo Viegas
E-mail(s) viegas@embl.de
Organization name EMBL-MMPU
Lab Kulozik/Hentze
Street address IM NEUENHEIMER FELD 156
City Heidelberg
ZIP/Postal code 69120
Country Germany
 
Platforms (1)
GPL96 [HG-U133A] Affymetrix Human Genome U133A Array
Samples (6)
GSM161670 HeLa cells control 1 (Luciferase siRNA transfection)
GSM161671 HeLa cells control 2 (Luciferase siRNA transfection)
GSM161674 HeLa cells control 3 (Luciferase siRNA transfection)
Relations
BioProject PRJNA99241

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE7009_RAW.tar 57.1 Mb (http)(custom) TAR (of CEL, CHP)
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap